subject: CHEBI:28748

object_name: FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Primary Peritoneal Transitional Cell Carcinoma

tested_intervention: unsure


subject: CHEBI:28748

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:28748

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:28748

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:28748

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:28748

object_name: Primary peritoneal carcinosarcoma


subject: CHEBI:28748

object_name: fallopian tube carcinosarcoma


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Recurrent ovarian cancer


subject: UNII:GN429E725A

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: UNII:GN429E725A

object_name: high grade ovarian serous adenocarcinoma


subject: UNII:GN429E725A

object_name: Recurrent Ovarian Carcinosarcoma


subject: UNII:GN429E725A

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UNII:GN429E725A

object_name: Recurrent Ovarian Transitional Cell Carcinoma


subject: UNII:GN429E725A

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:GN429E725A

object_name: Recurrent Ovarian Mucinous Adenocarcinoma


subject: UNII:GN429E725A

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UNII:GN429E725A

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:GN429E725A

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: UNII:GN429E725A

object_name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: UNII:GN429E725A

object_name: undifferentiated ovarian carcinoma


subject: UNII:GN429E725A

object_name: Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


subject: UNII:GN429E725A

object_name: Endometrial High Grade Endometrioid Adenocarcinoma


subject: UNII:GN429E725A

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:GN429E725A

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: UNII:GN429E725A

object_name: ovarian seromucinous carcinoma


subject: UNII:GN429E725A

object_name: Primary Peritoneal Undifferentiated Carcinoma


subject: UNII:GN429E725A

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:GN429E725A

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


subject: UNII:GN429E725A

object_name: FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


subject: UNII:GN429E725A

object_name: Primary Peritoneal Transitional Cell Carcinoma


subject: UNII:GN429E725A

object_name: fallopian tube clear cell adenocarcinoma


subject: UNII:GN429E725A

object_name: fallopian tube transitional cell carcinoma


subject: UNII:GN429E725A

object_name: fallopian tube endometrioid adenocarcinoma


subject: UNII:GN429E725A

object_name: fallopian tube mucinous adenocarcinoma


subject: UNII:GN429E725A

object_name: Primary peritoneal carcinosarcoma


subject: UNII:GN429E725A

object_name: fallopian tube carcinosarcoma


subject: CHEBI:6801

subject_name: Metformin

object_name: abdominal aortic aneurysm

tested_intervention: yes


subject: CHEBI:6801

object_name: aortic aneurysm, familial abdominal, 1


subject: CHEBI:95129

subject_name: cisapride

object_name: gastroparesis


subject: CHEBI:95129

object_name: Gastroparesis, CTCAE


subject: CHEBI:10125

subject_name: Zolpidem

object_name: focal dystonia


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Infection of musculoskeletal system


subject: CHEBI:100241

object_name: Ascites


subject: CHEBI:100241

object_name: Ascites, CTCAE


subject: CHEBI:100241

object_name: Cirrhosis


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: acute leukemia


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: cancer of cerebellum


subject: UMLS:C1527137

object_name: Mental deterioration


subject: UMLS:C1527137

object_name: Cognitive impairment


subject: UMLS:C1527137

object_name: Alzheimer disease type 1


subject: UMLS:C1527137

object_name: Alzheimer disease


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: UMLS:C5555041

subject_name: Emfizatamab

object_name: EXCESS LMW-DNA


subject: UNII:DR6P1M58PO

subject_name: EFINOPEGDUTIDE

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C5139821

subject_name: Efinopegdutide


subject: UNII:GT0I9SV4F6

subject_name: Mavoglurant

object_name: cocaine use disorder


subject: UMLS:C5139893

subject_name: gedivumab

object_name: influenza A


subject: UMLS:C5139963


subject: CHEBI:50659

subject_name: Dronedarone

object_name: heart failure


subject: CHEBI:50659

object_name: congestive heart failure


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: multiple sclerosis


subject: CHEBI:28887

object_name: retinal degeneration


subject: CHEBI:28887

object_name: Visual Acuity


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C3641866

object_name: prostate carcinoma


subject: UMLS:C3641866

object_name: prostate cancer


subject: UMLS:C3641866

object_name: metastatic prostate carcinoma


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: neoplasm


subject: UMLS:C4048878

subject_name: MGCD 0103


subject: CHEBI:177416

subject_name: Pexacerfont

object_name: endogenous depression


subject: CHEBI:177416

object_name: major depressive disorder


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Duchenne muscular dystrophy


subject: PUBCHEM.COMPOUND:147740

subject_name: Yasmin

object_name: Androgen excess


subject: UMLS:C0939533


subject: UMLS:C2983764

object_name: metastatic colorectal cancer


subject: CHEBI:231693

subject_name: Capmatinib


subject: UMLS:C0052350

subject_name: arginyl-glycyl-aspartic acid

object_name: Atrophy of alveolar ridges


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: trigeminal neuralgia


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEMBL.COMPOUND:CHEMBL2108126

subject_name: PSYLLIUM HUSK

object_name: Low Anterior Resection Syndrome


subject: DRUGBANK:DB11097

subject_name: Plantago seed


subject: CHEBI:165446

subject_name: Psyllic acid


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Mycoses


subject: UMLS:C0812735

object_name: cardiac arrest


subject: UMLS:C0812735

object_name: Cardiorespiratory arrest


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: MESH:C000593083

subject_name: RUC-4 compound

object_name: myocardial infarction


subject: MESH:C000593083

object_name: Myocardial Infarction, CTCAE


subject: MESH:C000593083

object_name: Myocardial Infarction by ECG Finding


subject: MESH:C000593083

object_name: ST-elevation myocardial infarction


subject: MESH:C000593083

object_name: coronary artery disorder


subject: MESH:C000593083

object_name: aneurysm


subject: MESH:C000593083

object_name: heart disorder


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Hemorrhage


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:232408

subject_name: Racemetyrosine

object_name: psychosis


subject: CHEBI:232408

object_name: Nonorganic psychosis


subject: CHEBI:232408

object_name: Psychosis, CTCAE


subject: CHEBI:232408

object_name: velocardiofacial syndrome


subject: CHEBI:232408

object_name: DiGeorge syndrome


subject: CHEBI:6912

subject_name: Metyrosine


subject: CHEBI:6912


subject: CHEBI:6912


subject: CHEBI:6912


subject: CHEBI:6912


subject: UMLS:C0051427

subject_name: Demser


subject: UMLS:C0051427


subject: UMLS:C0051427


subject: UMLS:C0051427


subject: UMLS:C0051427


subject: MESH:C000709231

object_name: Miller-Dieker lissencephaly syndrome


subject: MESH:C000709231

object_name: myoclonic dystonia 11


subject: MESH:C000709231

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5706424

subject_name: LCB 73

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5706424

object_name: B-cell neoplasm


subject: UMLS:C5706424

object_name: mantle cell lymphoma


subject: UMLS:C5706424

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5706424

object_name: follicular lymphoma


subject: UMLS:C1327844

object_name: cervical cancer


subject: UMLS:C1327844

object_name: cervical carcinoma


subject: UMLS:C1327844

object_name: uterine cervix carcinoma in situ


subject: UMLS:C1327844

object_name: human papilloma virus infection


subject: CHEBI:81686

subject_name: Magnesium L-ascorbic acid-2-phosphate

object_name: Childhood Breast Carcinoma


subject: CHEBI:81686

object_name: breast carcinoma


subject: CHEBI:81686

object_name: breast cancer


subject: CHEBI:28055

subject_name: aminoparathion


subject: CHEBI:28055


subject: CHEBI:28055


subject: CHEBI:155848

subject_name: Ala-Pro


subject: CHEBI:155848


subject: CHEBI:155848


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: CHEBI:28971


subject: UMLS:C0002059

subject_name: Alkaline Phosphatase


subject: UMLS:C0002059


subject: UMLS:C0002059


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000014196


subject: PR:000014196


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: UMLS:C5556485

subject_name: Hedgehog Inhibitor NLM-001

object_name: pancreatic ductal adenocarcinoma


subject: UNII:FE7L22H028

subject_name: ZALIFRELIMAB


subject: UMLS:C4287792


subject: CHEBI:91899

object_name: Liver transplant rejection


subject: CHEBI:91899

object_name: Acute cellular graft rejection


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:17026

subject_name: Progesterone

object_name: Threatened premature labor


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: leukemia


subject: PUBCHEM.COMPOUND:137706467

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:137706467

object_name: plasma cell myeloma


subject: UMLS:C2713028

subject_name: ABI 009

object_name: Drug Resistant Epilepsy


subject: UMLS:C4053590

subject_name: Cifurtilimab

object_name: melanoma


subject: UMLS:C4053590

object_name: non-small cell lung carcinoma


subject: UMLS:C1815093

subject_name: Coreg CR

object_name: hypertension


subject: UMLS:C1815093

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: PUBCHEM.COMPOUND:596

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:94265

subject_name: Cerubidin

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:94265

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:94265


subject: CHEBI:94265

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:94265


subject: CHEBI:94265

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:94265

object_name: adult acute monocytic leukemia


subject: CHEBI:94265

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:94265

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: PUBCHEM.COMPOUND:18140

object_name: metastatic prostate carcinoma


subject: CHEBI:4868

subject_name: Estramustine


subject: UNII:GO90DFK14U

subject_name: inolimomab

object_name: Steroid Resistant Acute Graft Versus Host Disease


subject: UMLS:C0905677


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767

object_name: Hypercholesterolemia


subject: PUBCHEM.COMPOUND:5281767

object_name: heart disorder


subject: PUBCHEM.COMPOUND:5281767

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:5281767

object_name: obesity


subject: PUBCHEM.COMPOUND:5281767

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: musculoskeletal system disorder


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:6801

subject_name: Metformin

object_name: Ovarian clear cell carcinoma


subject: CHEBI:6801

object_name: ovarian clear cell cancer


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UniProtKB:P15993

subject_name: AROP_ECOLI Aromatic amino acid transport protein AroP (sprot)

object_name: inherited lipid metabolism disorder


subject: UniProtKB:P15993

object_name: Dyslipidemia


subject: UMLS:C1720919

subject_name: Zostavax

object_name: fibrosis


subject: UMLS:C0533389

object_name: sleep disorder, initiating and maintaining sleep


subject: UMLS:C0533389

object_name: insomnia


subject: DRUGBANK:DB05418


subject: DRUGBANK:DB05418


subject: UNII:7WWH5KNA35

subject_name: phenylsaligenin cyclic phosphate

object_name: lip and oral cavity carcinoma


subject: UNII:7WWH5KNA35

object_name: oral cavity cancer


subject: UMLS:C5854349

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854349

object_name: non-small cell lung carcinoma


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEBI:9241

object_name: hypertrophic cardiomyopathy


subject: CHEBI:9241

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:32250

subject_name: tramadol hydrochloride

object_name: nephrolithiasis


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:16796

subject_name: Melatonin

object_name: generalized epilepsy


subject: CHEBI:16796

object_name: idiopathic generalized epilepsy


subject: CHEBI:45716

subject_name: Vorinostat

object_name: neoplasm


subject: DRUGBANK:DB05948

object_name: Hypercholesterolemia


subject: CHEBI:31348

subject_name: Capecitabine

object_name: hormone receptor-positive breast cancer


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UMLS:C4053601


subject: PUBCHEM.COMPOUND:3473

subject_name: Gingerol

object_name: lichen planus, oral


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UNII:S052TOI9BI

subject_name: Vestipitant

object_name: social phobia


subject: CHEBI:2668

subject_name: Amlodipine

object_name: cardiovascular disorder


subject: CHEBI:31247

subject_name: Azelnidipine

object_name: hypertension


subject: CHEBI:31247

object_name: Hypertension, CTCAE


subject: CHEBI:31247


subject: CHEBI:31932

subject_name: olmesartan


subject: UMLS:C5417792

subject_name: MC1R Agonist MT-7117

object_name: diffuse cutaneous systemic sclerosis


subject: UMLS:C5417792

object_name: diffuse scleroderma


subject: PR:000003252

subject_name: antithrombin-III

object_name: hereditary antithrombin deficiency


subject: GTOPDB:13543

subject_name: inotersen

object_name: Pregnant


subject: UNII:0IEO0F56LV

subject_name: Inotersen


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: Dysesthesia


subject: UMLS:C3536836

subject_name: Local Anesthetic [EPC]


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:36791

subject_name: Escitalopram

object_name: alcohol abuse


subject: CHEBI:36791

object_name: alcohol dependence


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:74704

subject_name: Met-Ile


subject: CHEBI:74704


subject: CHEBI:53620

subject_name: Methylisothiazolinone


subject: CHEBI:53620


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:24848


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Periorbital hyperpigmentation


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UNII:01DZ4127G7

object_name: lung cancer


subject: UNII:01DZ4127G7

object_name: lung neoplasm


subject: UNII:01DZ4127G7

object_name: lung carcinoma


subject: CHEBI:135702

subject_name: Belotecan


subject: CHEBI:135702


subject: CHEBI:135702


subject: UMLS:C1879797

subject_name: belotecan hydrochloride


subject: UMLS:C1879797


subject: UMLS:C1879797


subject: CHEBI:151315

subject_name: Heparin

object_name: Regional anesthesia morbidity


subject: CHEBI:151315

object_name: Anticoagulants and Bleeding Disorders


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880


subject: CHEBI:231594

subject_name: Norgestrel

object_name: HIV infection


subject: CHEBI:119486

subject_name: Efavirenz

object_name: Uses contraception (finding)


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: neoplastic meningitis


subject: GTOPDB:13627

subject_name: zanidatamab

object_name: gastroesophageal adenocarcinoma


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UMLS:C4331966


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:435949

object_name: prostate cancer


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Malignant neoplasm of stomach stage II


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:39585

subject_name: Carbidopa

object_name: wound of forehead


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: chronic leukemia


subject: UMLS:C3641791


subject: CHEBI:76978

subject_name: Tricaprylin

object_name: Alzheimer disease type 1


subject: CHEBI:76978

object_name: Alzheimer disease


subject: CHEBI:91414

subject_name: Adavosertib

object_name: pancreatic adenocarcinoma


subject: UMLS:C2934122


subject: UMLS:C2981200

subject_name: MAGE-3.A1 Peptide Vaccine

object_name: metastatic melanoma


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: CHEBI:125628

subject_name: Alisertib

object_name: Mantle cell lymphoma refractory


subject: CHEBI:125628

object_name: B-cell lymphoma refractory


subject: CHEBI:125628

object_name: Burkitt's lymphoma refractory


subject: CHEBI:125628

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:125628

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:125628

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:125628

object_name: Follicular lymphoma refractory


subject: CHEBI:125628

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:125628

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:125628

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:125628

object_name: Recurrent Burkitt Lymphoma


subject: CHEBI:125628

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:125628

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:125628

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:125628

object_name: B-cell lymphoma recurrent


subject: CHEBI:125628

object_name: Follicular lymphoma recurrent


subject: CHEBI:125628

object_name: MYC Positive


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Mantle cell lymphoma refractory


subject: CHEBI:61080

object_name: B-cell lymphoma refractory


subject: CHEBI:61080

object_name: Burkitt's lymphoma refractory


subject: CHEBI:61080

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:61080

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Follicular lymphoma refractory


subject: CHEBI:61080

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:61080

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:61080

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:61080

object_name: Recurrent Burkitt Lymphoma


subject: CHEBI:61080

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:61080

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:61080

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:61080

object_name: B-cell lymphoma recurrent


subject: CHEBI:61080

object_name: Follicular lymphoma recurrent


subject: CHEBI:61080

object_name: MYC Positive


subject: UMLS:C0963679

object_name: Mantle cell lymphoma refractory


subject: UMLS:C0963679

object_name: B-cell lymphoma refractory


subject: UMLS:C0963679

object_name: Burkitt's lymphoma refractory


subject: UMLS:C0963679

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C0963679

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C0963679

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C0963679

object_name: Follicular lymphoma refractory


subject: UMLS:C0963679

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C0963679

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C0963679

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0963679

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C0963679

object_name: Recurrent Burkitt Lymphoma


subject: UMLS:C0963679

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UMLS:C0963679

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C0963679

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C0963679

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C0963679

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C0963679

object_name: B-cell lymphoma recurrent


subject: UMLS:C0963679

object_name: Follicular lymphoma recurrent


subject: UMLS:C0963679

object_name: MYC Positive


subject: DRUGBANK:DB15074

subject_name: Aglatimagene besadenovec

object_name: pancreatic neoplasm


subject: DRUGBANK:DB15074

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB15074

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB15074

object_name: pancreatic adenocarcinoma


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:47426

subject_name: Furosemide

object_name: Dyspnea


subject: MESH:C511723

subject_name: zodin

object_name: myocardial infarction


subject: MESH:C511723

object_name: Myocardial Infarction, CTCAE


subject: MESH:C511723

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:132922

object_name: migraine


subject: CHEBI:132922

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UNII:R6OS9S8VQ7

subject_name: EFEPOETIN ALFA

object_name: Anemia in chronic kidney disease


subject: UMLS:C5418363

subject_name: Efepoetin alfa


subject: UMLS:C1883340

subject_name: Inno-hep

object_name: Deep vein thrombosis of lower limb


subject: UMLS:C1883340

object_name: Deep venous thrombosis


subject: CHEBI:9168

subject_name: Sirolimus

object_name: cardiovascular disorder


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Non-erosive gastro-esophageal reflux disease


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: alcohol-related disorders


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:15727

subject_name: Carnosine

object_name: persian gulf syndrome


subject: UMLS:C0007267

subject_name: carnosine


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: portal hypertension


subject: PUBCHEM.COMPOUND:16129681

object_name: Portal Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:16129681

object_name: chronic liver failure


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Intraoperative Complication


subject: CHEBI:4466

object_name: obstructive lung disease


subject: CHEBI:4466

object_name: Snoring


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931

object_name: 3MC syndrome 2


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: adrenogenital syndrome


subject: PUBCHEM.COMPOUND:21879648

object_name: congenital adrenal hyperplasia


subject: RXCUI:2648470

subject_name: mometasone furoate Nasal Spray

object_name: Nasal Polyp


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: arthropathy of shoulder region


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: Atopic rhinitis


subject: PUBCHEM.COMPOUND:2307

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:3001

subject_name: beclomethasone


subject: UNII:86R4PEJ40Z

object_name: hepatitis C


subject: UNII:MK831RYX9D


subject: CHEMBL.COMPOUND:CHEMBL2109648

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL2109648

object_name: Pruritus, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2109648

object_name: Pruritus


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Advanced breast cancer


subject: UNII:Z5MR2Y1IJJ

subject_name: Enavogliflozin

object_name: atrial fibrillation


subject: UNII:Z5MR2Y1IJJ

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:Z5MR2Y1IJJ

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:29191

subject_name: hydroxyl

object_name: cardiovascular disorder


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: bladder tumor


subject: GTOPDB:12966

object_name: urinary bladder carcinoma


subject: GTOPDB:12966

object_name: urinary bladder cancer


subject: GTOPDB:12966

object_name: childhood bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: CHEBI:600103

subject_name: daptomycin

object_name: Organ or tissue replaced by other means, heart assist device


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C3827082


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: metastatic colorectal cancer


subject: UNII:6XG22YQM2Z

object_name: colorectal cancer


subject: UNII:6XG22YQM2Z

object_name: colorectal carcinoma


subject: UNII:6XG22YQM2Z

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: DRUGBANK:DB10447

subject_name: Saccharomyces cerevisiae

object_name: irritable bowel syndrome


subject: CHEBI:6121

subject_name: Ketamine

object_name: Suicide threat


subject: UMLS:C3640128

subject_name: Indium In 111 Anti-CD45 Monoclonal Antibody BC8

object_name: refractory hairy cell leukemia


subject: UMLS:C3640128

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C3640128

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C3640128

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C3640128

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C3640128

object_name: anaplastic large cell lymphoma


subject: UMLS:C3640128

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C3640128

object_name: MALT lymphoma


subject: UMLS:C3640128

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C3640128

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C3640128

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C3640128

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C3640128

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C3640128

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C3640128

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C3640128

object_name: testicular lymphoma


subject: UMLS:C3640128

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C3640128

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C3640128

object_name: splenic marginal zone lymphoma


subject: UMLS:C3640128

object_name: intraocular lymphoma


subject: UMLS:C3640128

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C3640128

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C3640128

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C3640128

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C3640128

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C3640128

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C3640128

object_name: small intestine lymphoma


subject: UMLS:C3640128

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C3640128

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C3640128

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C3640128

object_name: noncutaneous extranodal lymphoma


subject: UMLS:C3640128

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C3640128

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C3640128

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C3640128

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C3640128

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C3640128

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:231679

subject_name: ipilimumab

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:231679

object_name: B-cell neoplasm


subject: CHEBI:231679

object_name: T-Cell Lymphoma


subject: CHEBI:231679

object_name: leukemia


subject: CHEBI:231679

object_name: childhood leukemia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C2713110

subject_name: SODIUM FLUORIDE F-18, DIAGNOSTIC, PER STUDY DOSE, UP TO 30 MILLICURIES

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2713110

object_name: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UMLS:C2713110

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: UMLS:C2713110

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: UMLS:C2713110

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C2713110

object_name: hypopharynx squamous cell carcinoma


subject: UMLS:C2713110

object_name: oropharynx squamous cell carcinoma


subject: UMLS:C2713110

object_name: laryngeal squamous cell carcinoma


subject: CHEBI:28741

subject_name: Sodium fluoride


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:125400

subject_name: actinomycin D

object_name: melanoma


subject: CHEBI:27666

subject_name: Dactinomycin


subject: UMLS:C0796329

subject_name: Neuradiab

object_name: glioblastoma


subject: UMLS:C0796329

object_name: Brain Stem Glioblastoma


subject: UMLS:C0796329

object_name: glioma susceptibility 1


subject: CHEBI:149504

object_name: mucopolysaccharidosis type 6


subject: CHEBI:149504

object_name: mucopolysaccharidosis


subject: CHEBI:149504

object_name: mucopolysaccharidosis type 4A


subject: CHEBI:149504

object_name: mucopolysaccharidosis type 4


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Nausea and vomiting


subject: CHEBI:42797


subject: CHEBI:95021

subject_name: pemetrexed

object_name: metastatic colorectal cancer


subject: CHEBI:63724


subject: CHEBI:50838

subject_name: Drospirenone

object_name: adenomyosis


subject: PUBCHEM.COMPOUND:50913622

subject_name: Delgocitinib

object_name: Chronic hand eczema


subject: CHEBI:31409

object_name: hepatitis C


subject: UMLS:C0772142

subject_name: clemizole HCl


subject: UMLS:C2700264

object_name: acute myeloid leukemia


subject: CHEBI:68595

subject_name: Telaprevir

object_name: opiate dependence


subject: CHEBI:180905

subject_name: Nicardipine

object_name: coronary artery disorder


subject: CHEBI:180905

object_name: coronary atherosclerosis


subject: CHEBI:180905

object_name: acute coronary syndrome


subject: CHEBI:4856

subject_name: Esmolol


subject: CHEBI:4856


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: ankylosing spondylitis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Advanced Endometrial Carcinoma


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Dental implant failed


subject: CHEBI:3614

object_name: Infection and inflammatory reaction due to internal orthopedic fixation device


subject: CHEBI:3614

object_name: Peri-implant mucositis


subject: CHEBI:16240

subject_name: Hioxyl


subject: CHEBI:16240


subject: CHEBI:16240

object_name: Peri-Implantitis


subject: CHEBI:16240


subject: UMLS:C5222458

subject_name: Ketamine Hydrochloride Injection

object_name: Suicidal ideation


subject: UMLS:C5222458

object_name: Suicidal Ideation, CTCAE


subject: UMLS:C5222458

object_name: bipolar depression


subject: UMLS:C5222458

object_name: major depressive disorder


subject: CHEMBL.COMPOUND:CHEMBL223620

subject_name: THIMEROSAL

object_name: influenza


subject: CHEBI:9546

subject_name: Thimerosal


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: MESH:C027128

subject_name: Antitumor B

object_name: oral cavity squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2171

object_name: pseudomyxoma peritonei


subject: PUBCHEM.COMPOUND:2171

object_name: appendiceal neoplasm


subject: UMLS:C0722795

subject_name: Prevpac


subject: UMLS:C0722795


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:6375

subject_name: Lansoprazole


subject: CHEBI:6375


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: stimulant use


subject: CHEBI:166520

object_name: poisoning or overdose by MDMA


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:1391


subject: UNII:13ZT6YG5SD

subject_name: methamphetamine


subject: CHEBI:6809

subject_name: Metamfetamine


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: UNII:BSOIY5AKQW

subject_name: ervogastat

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:BSOIY5AKQW


subject: UMLS:C5828636


subject: UMLS:C5828636


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Recurrent Urethral Cancer


subject: CHEBI:49900

object_name: transitional cell carcinoma


subject: CHEBI:49900

object_name: ureter cancer


subject: CHEBI:49900

object_name: ureter carcinoma


subject: CHEBI:49900

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:69477

subject_name: Cannabigerol

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: periodontitis, aggressive 1


subject: CHEBI:60648

object_name: acute pericementitis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Vaccine response impaired


subject: UMLS:C2984025

object_name: anemia deficiency iron treatment


subject: UMLS:C2984025

object_name: Vaccine-Preventable Diseases


subject: CHEBI:17015

subject_name: Riboflavin

object_name: Blood Pressure Finding


subject: CHEBI:17015

object_name: Systemic arterial pressure


subject: CHEBI:17015

object_name: hypertension


subject: CHEBI:17015

object_name: Hypertension, CTCAE


subject: CHEBI:72296

subject_name: Apixaban

object_name: Upper Extremity Deep Vein Thrombosis


subject: CHEBI:72296

object_name: Thrombus


subject: UNII:283FTA936D

object_name: atopic eczema


subject: UNII:7LBRZUYSHU

subject_name: Branebrutinib


subject: UMLS:C0310090

subject_name: SALINE SOLUTION 0.9%

object_name: type 2 diabetes mellitus


subject: CHEBI:32696


subject: UMLS:C5417764

subject_name: Photrex

object_name: macular degeneration


subject: UMLS:C5417764

object_name: age-related macular degeneration


subject: UMLS:C5417764

object_name: retinitis pigmentosa 30


subject: PUBCHEM.COMPOUND:135565472

subject_name: Rostaporfin


subject: PUBCHEM.COMPOUND:135565472


subject: PUBCHEM.COMPOUND:135565472


subject: UNII:466G63QE7G

subject_name: ROSTAPORFIN


subject: UNII:466G63QE7G


subject: UNII:466G63QE7G


subject: UMLS:C5139837

subject_name: Pegadricase

object_name: Hyperuricemia


subject: UMLS:C5139837

object_name: Hyperuricemia, CTCAE


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: venous thromboembolism


subject: UNII:IY90U61Z3S

object_name: thrombophilia due to thrombin defect


subject: UNII:IY90U61Z3S

object_name: female reproductive system neoplasm


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: UNII:0DW7MIH1VX


subject: UNII:0DW7MIH1VX


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:48720


subject: CHEBI:48720


subject: UMLS:C4310555

object_name: respiratory tract infectious disorder


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: Infantile Colic


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Acne inversa


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Childhood Breast Carcinoma


subject: CHEBI:74705

object_name: breast carcinoma


subject: CHEBI:74705

object_name: breast cancer


subject: CHEBI:74705

object_name: Post-Mastectomy Pain Syndrome


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: lymphoid interstitial pneumonia


subject: CHEBI:60648

object_name: benign neoplasm of lip


subject: CHEBI:60648

object_name: Neoplasm of uncertain or unknown behavior of larynx


subject: CHEBI:60648

object_name: laryngeal disorder


subject: CHEBI:60648

object_name: larynx carcinoma in situ


subject: CHEBI:60648

object_name: benign laryngeal neoplasm


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:149504

object_name: Renal transplant failure


subject: CHEBI:149504

object_name: Cardiac complication


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: open-angle glaucoma


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:28887

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:28887

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:28887

object_name: Chronic lymphocytic leukaemia stage 3


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: Advanced cancer


subject: UNII:820NH671E6

object_name: squamous cell carcinoma


subject: UNII:820NH671E6

object_name: head and neck squamous cell carcinoma


subject: UNII:820NH671E6

object_name: anal margin carcinoma


subject: UNII:820NH671E6

object_name: anal squamous cell carcinoma


subject: UNII:820NH671E6

object_name: non-small cell lung carcinoma


subject: UNII:820NH671E6

object_name: Lung squamous cell carcinoma metastatic


subject: CHEBI:50749

subject_name: Calcipotriol


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Gastric carcinoma stage IV


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:54675783

object_name: head and neck cancer


subject: CHEBI:8378

subject_name: Prednisolone

object_name: lupus nephritis


subject: UNII:NU90V55F8I

subject_name: Sarilumab

object_name: sarcoidosis


subject: UNII:NU90V55F8I

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:17632

subject_name: Nitrate

object_name: Maternal care for late fetal death


subject: CHEBI:17632

object_name: Cervical pregnancy


subject: CHEBI:6061

subject_name: Isosorbide dinitrate


subject: CHEBI:6061


subject: PUBCHEM.COMPOUND:130310079

object_name: obstructive sleep apnea syndrome


subject: UMLS:C0260264

subject_name: steroid drugs

object_name: Premature Labor


subject: UMLS:C0260264

object_name: chorioamnionitis


subject: UMLS:C0260264

object_name: Premature birth


subject: UMLS:C0260264

object_name: amniocentesis affecting fetus or newborn


subject: UMLS:C0040349

subject_name: Tocolytic Agents


subject: UMLS:C0040349


subject: UMLS:C0040349


subject: CHEMBL.COMPOUND:CHEMBL5095278

subject_name: LORIGERLIMAB

object_name: rectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: rectal cancer


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Childhood Rectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Recurrent Rectal Cancer


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:6801

subject_name: Metformin

object_name: lactic acidosis


subject: CHEBI:46662

subject_name: mineral

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:46662


subject: CHEBI:33704

subject_name: Amino acid


subject: CHEBI:33704


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: GTOPDB:13714

subject_name: paridiprubart

object_name: acute respiratory distress syndrome


subject: GTOPDB:13714

object_name: adult acute respiratory distress syndrome


subject: GTOPDB:13714

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: GTOPDB:13714

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: CHEMBL.COMPOUND:CHEMBL5095366

subject_name: PARIDIPRUBART


subject: CHEMBL.COMPOUND:CHEMBL5095366


subject: CHEMBL.COMPOUND:CHEMBL5095366


subject: CHEMBL.COMPOUND:CHEMBL5095366


subject: UMLS:C4507205


subject: UMLS:C4507205


subject: UMLS:C4507205


subject: UMLS:C4507205


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:567361

subject_name: Cladribine

object_name: Refractory Myeloid Neoplasm


subject: CHEBI:567361

object_name: mixed phenotype acute leukemia


subject: CHEBI:567361

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:567361

object_name: Recurrent Myeloid Sarcoma


subject: CHEBI:567361

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: CHEBI:567361

object_name: Refractory Acute Biphenotypic Leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: UMLS:C0376562

subject_name: Recombinant Granulocyte Colony Stimulating Factor

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0376562

object_name: acute myeloid leukemia


subject: UMLS:C0376562


subject: UMLS:C0376562

object_name: acute biphenotypic leukemia


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562

object_name: Infant Acute Biphenotypic Leukemia


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: Drug Interactions


subject: CHEBI:31536

object_name: Adverse drug interaction


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:60481


subject: CHEBI:60481


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PR:000008953


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Immune Tolerance


subject: CHEBI:66964

object_name: Drug Tolerance


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: melancholia


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: knee pain chronic


subject: PUBCHEM.COMPOUND:54671203

object_name: osteoarthritis


subject: CHEBI:33353

subject_name: technetium atom

object_name: Stage IV Liver Cancer


subject: CHEBI:33353

object_name: Stage IV Adult Liver Cancer AJCC v7


subject: CHEBI:33353

object_name: Hepatic cancer stage IVA


subject: CHEBI:33353

object_name: Stage IVB Liver Cancer


subject: CHEBI:33353

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:33353

object_name: liver carcinoma


subject: CHEBI:33353

object_name: Thrombosis of blood vessel


subject: CHEBI:6121

subject_name: Ketamine

object_name: Chronic low back pain


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Acute Pain


subject: CHEBI:132922

object_name: Inguinal hernia


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:135089

subject_name: Propacetamol


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: juvenile pilocytic astrocytoma


subject: PUBCHEM.COMPOUND:188025

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:188025

object_name: obesity


subject: PUBCHEM.COMPOUND:188025

object_name: Obesity, CTCAE


subject: CHEBI:228596

subject_name: MPH


subject: CHEBI:228596


subject: CHEBI:228596


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:6887


subject: CHEBI:6887


subject: PR:000002069


subject: PR:000002069


subject: PR:000002069


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Gastroesophageal junction cancer


subject: RXCUI:2119701

subject_name: latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution

object_name: OPTN-related open angle glaucoma


subject: RXCUI:2119701

object_name: open-angle glaucoma


subject: RXCUI:1421451

subject_name: brimonidine tartrate 2 MG/ML / brinzolamide 10 MG/ML Ophthalmic Suspension


subject: RXCUI:1421451


subject: UMLS:C4045524

object_name: cancer


subject: UMLS:C4045524

object_name: adult lymphoma


subject: UMLS:C4045524

object_name: lymphoma


subject: UMLS:C4045524

object_name: pediatric lymphoma


subject: UMLS:C4045524

object_name: Primary malignant neoplasm


subject: UMLS:C2983774

subject_name: Iap inhibitor at-406


subject: UMLS:C2983774

object_name: neoplasm


subject: UMLS:C2983774

object_name: Solid Neoplasm


subject: UMLS:C2983774


subject: UMLS:C2983774


subject: UMLS:C2983774


subject: UMLS:C2983774


subject: PUBCHEM.COMPOUND:22833548

subject_name: N-Glycoloylganglioside GM1

object_name: Parkinson disease


subject: CHEBI:61048

subject_name: Ganglioside GM1


subject: CHEBI:81916

subject_name: Pancrelipase

object_name: pancreas disorder


subject: CHEBI:81916

object_name: digestive system disorder


subject: UNII:FQ3DRG0N5K


subject: UNII:FQ3DRG0N5K


subject: UMLS:C0111046

subject_name: Creon


subject: UMLS:C0111046


subject: UMLS:C1302030

subject_name: amylase / lipase / protease


subject: UMLS:C1302030


subject: CHEBI:83766

subject_name: Olaparib

object_name: glioma


subject: CHEBI:83766

object_name: malignant glioma


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: esophageal adenocarcinoma


subject: CHEBI:68646


subject: CHEBI:68646

object_name: gastric adenocarcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: UMLS:C3180100

object_name: major depressive disorder


subject: CHEBI:31348

subject_name: Capecitabine

object_name: pancreatic endocrine carcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UNII:1IJV77EI07

subject_name: Tepotinib

object_name: MET gene amplification


subject: UNII:1IJV77EI07

object_name: MET Exon 14 Skipping Mutation


subject: UNII:0I621Y6R4Q

subject_name: K201 compound

object_name: atrial fibrillation


subject: UNII:0I621Y6R4Q

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:0I621Y6R4Q

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Local anaesthetic systemic toxicity


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: vitamin K measurement


subject: PUBCHEM.COMPOUND:4056

object_name: Inflammation


subject: PUBCHEM.COMPOUND:4056

object_name: Increased reactive oxygen species production


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: UNII:71ANL51TLA


subject: UNII:71ANL51TLA


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: CHEBI:28869


subject: CHEBI:28869


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: UNII:12V8PA4WCH


subject: UNII:12V8PA4WCH


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:16374


subject: CHEBI:16374


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Other Intra-Operative Injury, CTCAE


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: diarrhea


subject: UMLS:C1440867

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C1440867

object_name: Diarrhea, CTCAE


subject: UMLS:C1440867

object_name: malnutrition


subject: PUBCHEM.COMPOUND:3367

object_name: esophageal cancer


subject: CHEBI:42588

subject_name: Fenretinide

object_name: unspecified adult solid tumor, protocol specific


subject: MESH:C000716647

object_name: allergic asthma


subject: MESH:C000716647

object_name: IgE-mediated allergic asthma


subject: MESH:C000716647

object_name: extrinsic asthma


subject: CHEBI:8871

subject_name: Risperidone

object_name: major depressive disorder


subject: CHEBI:25902

subject_name: pentyl group

object_name: post-traumatic stress disorder


subject: CHEBI:25902

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:25902

object_name: endogenous depression


subject: CHEBI:25902


subject: CHEBI:25902

object_name: mal de Debarquement


subject: CHEBI:25902

object_name: Minimal Disseminated Disease


subject: CHEBI:17553


subject: CHEBI:17553


subject: CHEBI:17553


subject: CHEBI:17553


subject: CHEBI:17553


subject: CHEBI:17553


subject: CHEBI:74762

subject_name: Pro-Glu


subject: CHEBI:74762


subject: CHEBI:74762


subject: CHEBI:74762


subject: CHEBI:74762


subject: CHEBI:74762


subject: CHEBI:16038

subject_name: phosphatidylethanolamine


subject: CHEBI:16038


subject: CHEBI:16038


subject: CHEBI:16038


subject: CHEBI:16038


subject: CHEBI:16038


subject: PR:000013200

subject_name: prolyl endopeptidase


subject: PR:000013200


subject: PR:000013200


subject: PR:000013200


subject: PR:000013200


subject: PR:000013200


subject: CHEBI:182913

subject_name: Dexpramipexole


subject: CHEBI:182913


subject: CHEBI:182913


subject: CHEBI:182913


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:8356


subject: CHEBI:8356


subject: DRUGBANK:DB11199

subject_name: Sage oil

object_name: Hot flashes


subject: PUBCHEM.COMPOUND:46874763


subject: UMLS:C4085979

object_name: Stage IV Lung Cancer AJCC v7


subject: UMLS:C4085979

object_name: squamous cell lung carcinoma


subject: UMLS:C2343504

subject_name: Aralast NP

object_name: type 1 diabetes mellitus 1


subject: UMLS:C2343504

object_name: type 1 diabetes mellitus


subject: CHEBI:135736

subject_name: Sitaxentan

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:6754

subject_name: Meperidine

object_name: Sedation


subject: CHEBI:6754

object_name: Sedated


subject: CHEBI:185135

subject_name: Polyvidone

object_name: Wound healed (finding)


subject: CHEBI:185135

object_name: Frontal balding


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: infiltrating bladder urothelial carcinoma


subject: UMLS:C0742246

subject_name: CHEMOTHERAPY CIS PLATIN


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Menopause present (finding)


subject: CHEBI:6715

object_name: Menopause


subject: CHEBI:6715

object_name: Hot Flashes, CTCAE


subject: CHEBI:6715


subject: CHEBI:138016

subject_name: MPA


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: CHEBI:6121

subject_name: Ketamine

object_name: complex regional pain syndrome


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: non-Hodgkin lymphoma


subject: MESH:C000613826


subject: CHEBI:188559

subject_name: Palovarotene

object_name: Multiple exostoses


subject: CHEBI:68855

subject_name: Ioflupane I-123

object_name: mild neurocognitive disorder


subject: CHEBI:68855

object_name: mild cognitive impairment


subject: CHEBI:68855

object_name: Presenile dementia


subject: CHEBI:68855

object_name: dementia


subject: CHEBI:68855

object_name: REM sleep behavior disorder


subject: CHEBI:68855

object_name: Parkinsonism


subject: UMLS:C2980484

subject_name: DaTscan


subject: UMLS:C2980484


subject: UMLS:C2980484


subject: UMLS:C2980484


subject: UMLS:C2980484


subject: UMLS:C2980484


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: Reduced left ventricular ejection fraction


subject: PUBCHEM.COMPOUND:54214995

object_name: Prosthetic heart valve


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:192614

subject_name: Homosildenafil


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UMLS:C3274844

object_name: Advanced cancer


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: type 2 diabetes mellitus


subject: UMLS:C2348756

object_name: Diabetes


subject: UMLS:C2348756

object_name: diabetes mellitus


subject: GTOPDB:8997

subject_name: ligelizumab

object_name: chronic idiopathic urticaria


subject: UNII:L8LE0L691T


subject: UMLS:C4041919


subject: CHEBI:6121

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:6121

object_name: obesity


subject: CHEBI:6121

object_name: Obesity, CTCAE


subject: CHEBI:35482

subject_name: opioid analgesic

object_name: Post-Operative Pain


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:3921

subject_name: Cromakalim

object_name: Common Migraine


subject: CHEBI:6436

subject_name: Levcromakalim


subject: UMLS:C0244960


subject: UMLS:C5446477

subject_name: Anti-HLA-G Antibody TTX-080

object_name: cancer


subject: UMLS:C5446477

object_name: neoplasm


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Stage IV Prostate Cancer AJCC v6


subject: UNII:68AYS9A614

object_name: Carcinoma of the prostate stage IV


subject: UNII:68AYS9A614

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: prostate adenocarcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:90876

subject_name: Lonsurf


subject: RXCUI:1670307

subject_name: tipiracil / trifluridine Oral Product

object_name: metastatic colorectal cancer


subject: RXCUI:1670307


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: chronic childhood arthritis


subject: CHEBI:3311

object_name: juvenile idiopathic arthritis


subject: UMLS:C0879430

object_name: colorectal cancer


subject: UMLS:C0879430

object_name: colorectal carcinoma


subject: UMLS:C0879430

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:63605

subject_name: Ixabepilone


subject: CHEBI:63605


subject: CHEBI:139072

object_name: borderline personality disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Rectal Cancer


subject: CHEBI:45716

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:45716

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:45716

object_name: Rectal cancer stage IV


subject: CHEBI:45716

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:45716

object_name: Colon cancer recurrent


subject: CHEBI:45716

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:45716

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:45716

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:45716

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:45716

object_name: colon adenocarcinoma


subject: CHEBI:45716

object_name: rectum adenocarcinoma


subject: UMLS:C1870424

object_name: Solid Neoplasm


subject: UMLS:C1870424

object_name: cancer


subject: UMLS:C1870424

object_name: neoplasm


subject: UMLS:C5441924

object_name: epilepsy


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Muscle cramps aggravated


subject: CHEBI:3160

object_name: diabetes mellitus


subject: UNII:W69HSF2416

subject_name: Levocetirizine Hydrochloride

object_name: Childhood Breast Carcinoma


subject: UNII:W69HSF2416

object_name: breast carcinoma


subject: UNII:W69HSF2416

object_name: breast cancer


subject: UMLS:C4743248

subject_name: levocetirizine hydrochloride


subject: UMLS:C4743248


subject: UMLS:C4743248


subject: CHEBI:94559

subject_name: Levocetirizine


subject: CHEBI:94559


subject: CHEBI:94559


subject: CHEBI:31980

subject_name: Perflutren

object_name: wet macular degeneration


subject: CHEBI:31980

object_name: Retinal hemorrhage


subject: CHEBI:37537

subject_name: Phorbol 12-myristate 13-acetate diester


subject: CHEBI:37537


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:53394

subject_name: phosphotungstic acid macromolecule


subject: CHEBI:53394


subject: CHEBI:61432

subject_name: phosphotungstic acid polymer


subject: CHEBI:61432


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: herpes simplex


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:8069

subject_name: Phenobarbital

object_name: fetal growth restriction


subject: CHEBI:681569

subject_name: Clofarabine

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: Marfan syndrome


subject: CHEBI:2904

subject_name: Atenolol


subject: UNII:5V1UI86573

subject_name: EZABENLIMAB

object_name: biliary tract cancer


subject: UNII:5V1UI86573

object_name: triple-negative breast carcinoma


subject: UNII:5V1UI86573

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:5V1UI86573

object_name: Adult Soft Tissue Sarcoma


subject: UNII:5V1UI86573

object_name: colorectal cancer


subject: UNII:5V1UI86573

object_name: colorectal carcinoma


subject: UNII:5V1UI86573

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:5V1UI86573

object_name: liver carcinoma


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4745006


subject: UMLS:C4745006


subject: UMLS:C4745006


subject: UMLS:C4745006

object_name: non-small cell lung carcinoma


subject: UMLS:C4745006


subject: UMLS:C4745006


subject: UMLS:C4745006


subject: UMLS:C4745006


subject: UMLS:C4745006


subject: CHEBI:145374

subject_name: Enasidenib

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: adult acute myeloid leukemia


subject: CHEBI:63791

object_name: childhood acute myeloid leukemia


subject: MESH:C011937

subject_name: mutagrip

object_name: influenza


subject: MESH:C011937

object_name: HIV infection


subject: CHEBI:125427

object_name: autosomal dominant hypocalcemia


subject: CHEBI:125427

object_name: Hypocalcemia


subject: CHEBI:125427

object_name: Serum calcium below normal (finding)


subject: CHEBI:125427

object_name: Hypocalcemia, CTCAE


subject: CHEBI:125427

object_name: thyroid disease


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:3311

subject_name: Calcium carbonate


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:3311


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Malignant Glioma


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: Cutaneous Melanoma In-Transit Metastasis


subject: UNII:8L7891MRB6

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371


subject: PUBCHEM.COMPOUND:46874763

object_name: Osteomyelitis of vertebra


subject: UMLS:C0003232

subject_name: Antibiotics


subject: CHEBI:188074

object_name: asthma


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEMBL.COMPOUND:CHEMBL4298079

object_name: Metastatic urothelial carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298079

object_name: Muscle Invasive Bladder Carcinoma


subject: UMLS:C3640822


subject: UMLS:C3640822


subject: CHEBI:74702

subject_name: Met-Glu

object_name: prostate carcinoma


subject: CHEBI:74702

object_name: prostate cancer


subject: CHEBI:74702

object_name: prostate neoplasm


subject: UNII:M4HNS35MM2

subject_name: ME


subject: UNII:M4HNS35MM2


subject: UNII:M4HNS35MM2


subject: PR:000010472

subject_name: macrophage metalloelastase


subject: PR:000010472


subject: PR:000010472


subject: PR:000016357


subject: PR:000016357


subject: PR:000016357


subject: UMLS:C0960676

subject_name: TARP


subject: UMLS:C0960676


subject: UMLS:C0960676


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5447426

subject_name: HSV- thymidine Kinase-m2/hGM-CSF Genes-encoding GEN2

object_name: Adult Solid Neoplasm


subject: CHEBI:63635

subject_name: Valganciclovir


subject: CHEBI:5959

subject_name: Irbesartan

object_name: hyperlipidemia


subject: CHEBI:5959

object_name: hyperlipoproteinemia


subject: CHEBI:5959

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:5959

object_name: Serum lipids high (finding)


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Mantle cell lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Mantle cell lymphoma recurrent


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UMLS:C4029782

subject_name: CFTR modulators

object_name: Cystic fibrosis in children


subject: UNII:7CS0WNO31M

subject_name: QUININE HYDROCHLORIDE

object_name: sinusitis


subject: UNII:7CS0WNO31M

object_name: Sinusitis, CTCAE


subject: UNII:7CS0WNO31M

object_name: rhinitis


subject: CHEBI:52251

subject_name: QUININE SULFATE


subject: CHEBI:52251


subject: CHEBI:52251


subject: CHEBI:94416


subject: CHEBI:94416


subject: CHEBI:94416


subject: CHEBI:15854

subject_name: Quinine


subject: CHEBI:15854


subject: CHEBI:15854


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: high-risk pregnancy


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:31348


subject: CHEBI:31348

object_name: MALT lymphoma


subject: CHEBI:31348

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:31348

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:31348

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: CHEBI:31348

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:31348

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:31348

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:31348

object_name: Immunoblastic lymphoma associated with AIDS


subject: CHEBI:31348

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:31348

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:31348

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:31348

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:31348

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:31348

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:31348

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:31348

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: CHEBI:31348

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:31348

object_name: Mantle cell lymphoma stage III


subject: CHEBI:31348

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:31348

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:31348

object_name: anaplastic large cell lymphoma


subject: CHEBI:31348

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:31348

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:31348

object_name: Burkitt lymphoma associated with AIDS


subject: CHEBI:31348

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:31348

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:31348

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:31348

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:31348

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:31348

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:31348

object_name: primary central nervous system Hodgkin lymphoma


subject: CHEBI:31348

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:31348

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:31348

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:31348

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:31348

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:31348

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:31348

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:31348

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:31348

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:31348

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:31348

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:31348

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:31348

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:31348

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:31348

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:31348

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:31348

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:31348

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:31348

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:31348

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:31348

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:31348

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:31348

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:31348

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: CHEBI:31348

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Marginal zone lymphoma stage III


subject: CHEBI:31348

object_name: AIDS-related primary central nervous system lymphoma


subject: CHEBI:31348

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:31348

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:31348

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:31348

object_name: splenic marginal zone lymphoma


subject: CHEBI:31348

object_name: AIDS-Related Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:31348

object_name: small intestine lymphoma


subject: CHEBI:31348

object_name: intraocular lymphoma


subject: CHEBI:31348

object_name: male breast carcinoma


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0379528

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0379528

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C0379528

object_name: MALT lymphoma


subject: UMLS:C0379528

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0379528

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C0379528

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: UMLS:C0379528

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0379528

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0379528

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0379528

object_name: Immunoblastic lymphoma associated with AIDS


subject: UMLS:C0379528

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0379528

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0379528

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UMLS:C0379528

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UMLS:C0379528

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0379528

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0379528

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0379528

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: UMLS:C0379528

object_name: Mantle cell lymphoma stage IV


subject: UMLS:C0379528

object_name: Mantle cell lymphoma stage III


subject: UMLS:C0379528

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C0379528

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C0379528

object_name: anaplastic large cell lymphoma


subject: UMLS:C0379528

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C0379528

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0379528

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C0379528

object_name: Burkitt lymphoma associated with AIDS


subject: UMLS:C0379528

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C0379528

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C0379528

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0379528

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0379528

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C0379528

object_name: central nervous system non-hodgkin lymphoma


subject: UMLS:C0379528

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C0379528

object_name: primary central nervous system Hodgkin lymphoma


subject: UMLS:C0379528

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UMLS:C0379528

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C0379528

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UMLS:C0379528

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UMLS:C0379528


subject: UMLS:C0379528

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C0379528

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C0379528

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C0379528

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C0379528

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C0379528

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C0379528

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C0379528

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C0379528

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C0379528

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C0379528

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C0379528

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UMLS:C0379528

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UMLS:C0379528

object_name: B-cell small lymphocytic lymphoma stage III


subject: UMLS:C0379528

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UMLS:C0379528

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UMLS:C0379528

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UMLS:C0379528

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C0379528

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UMLS:C0379528

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UMLS:C0379528

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UMLS:C0379528

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: UMLS:C0379528

object_name: Stage III Adult Hodgkin Lymphoma


subject: UMLS:C0379528

object_name: Marginal zone lymphoma stage III


subject: UMLS:C0379528

object_name: AIDS-related primary central nervous system lymphoma


subject: UMLS:C0379528

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C0379528

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C0379528

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C0379528

object_name: Marginal zone lymphoma stage IV


subject: UMLS:C0379528

object_name: splenic marginal zone lymphoma


subject: UMLS:C0379528

object_name: AIDS-Related Hodgkin Lymphoma


subject: UMLS:C0379528

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C0379528

object_name: small intestine lymphoma


subject: UMLS:C0379528

object_name: Stage III Rectal Cancer AJCC v6


subject: UMLS:C0379528

object_name: Stage III Rectal Cancer AJCC v7


subject: UMLS:C0379528

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C0379528

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage III Colon Cancer


subject: UMLS:C0379528

object_name: intraocular lymphoma


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: sleep disorder, initiating and maintaining sleep


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Neuroblastoma recurrent


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: acute myocardial infarction


subject: UNII:X85G7936GV

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:6402

subject_name: Leflunomide

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: hypertension


subject: CHEBI:15355

object_name: Hypertension, CTCAE


subject: CHEBI:15355

object_name: chronic obstructive pulmonary disease


subject: CHEBI:15355

object_name: pulmonary hypertension


subject: CHEBI:15355

object_name: heart failure


subject: CHEBI:15355

object_name: Heart Failure, CTCAE


subject: CHEBI:29321

subject_name: sodium nitroprusside


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:5748345

subject_name: ANGIOTENSIN-II


subject: PUBCHEM.COMPOUND:5748345


subject: PUBCHEM.COMPOUND:5748345


subject: PUBCHEM.COMPOUND:5748345


subject: PUBCHEM.COMPOUND:5748345


subject: PUBCHEM.COMPOUND:5748345


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:33569


subject: CHEBI:33569


subject: CHEBI:33569


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:8081

subject_name: Phentolamine


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:8081


subject: CHEBI:15372


subject: CHEBI:15372


subject: CHEBI:15372


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E


subject: PUBCHEM.COMPOUND:5320784


subject: PUBCHEM.COMPOUND:5320784


subject: PUBCHEM.COMPOUND:5320784


subject: PUBCHEM.COMPOUND:5320784


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: CHEBI:59560


subject: CHEBI:124959

subject_name: Tilarginine


subject: CHEBI:124959


subject: CHEBI:124959


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:2965


subject: CHEBI:2965


subject: CHEBI:2965


subject: CHEBI:2965


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C5690696

subject_name: MitoQ


subject: UMLS:C5690696


subject: UMLS:C5690696


subject: UMLS:C5690696


subject: UMLS:C5690696


subject: CHEBI:5050

subject_name: Fexofenadine


subject: CHEBI:5050


subject: CHEBI:5050


subject: CHEBI:5050


subject: CHEBI:5050


subject: CHEBI:5050


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: UNII:884KT10YB7


subject: UNII:884KT10YB7


subject: UNII:884KT10YB7


subject: UNII:884KT10YB7


subject: UNII:884KT10YB7


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: CHEBI:8776


subject: CHEBI:8776


subject: CHEBI:8776


subject: CHEBI:8776


subject: GTOPDB:13796

subject_name: serplulimab

object_name: lung adenocarcinoma


subject: GTOPDB:13796

object_name: Metastatic non-small cell lung cancer


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered


subject: UMLS:C1508862


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C2729368


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UMLS:C5203354


subject: UMLS:C0879373

subject_name: Iodinated Contrast Agent

object_name: skin melanoma


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Klatskin Tumor


subject: CHEBI:30830

subject_name: sodium oxybate


subject: CHEBI:30830

object_name: insomnia


subject: UNII:B6840JH4EB

subject_name: BATIRAXCEPT

object_name: nonpapillary renal cell carcinoma


subject: UNII:B6840JH4EB

object_name: clear cell renal carcinoma


subject: UMLS:C4733686


subject: UMLS:C4733686


subject: UNII:6SN82Y9U73

subject_name: FORODESINE HYDROCHLORIDE

object_name: cancer


subject: UNII:6SN82Y9U73

object_name: neoplasm


subject: UMLS:C1997549

subject_name: Forodesine hydrochloride


subject: UMLS:C1997549


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: kidney failure


subject: PUBCHEM.COMPOUND:1805

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:1805

object_name: liver disorder


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:93776

subject_name: Pevonedistat


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:93776


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Neonatal Opiate Withdrawal Syndrome


subject: PUBCHEM.COMPOUND:9848990

object_name: Harmful pattern of substance use


subject: PUBCHEM.COMPOUND:9848990

object_name: Drug Abuse in Pregnancy


subject: PUBCHEM.COMPOUND:9848990

object_name: pregnancy related


subject: CHEBI:52717

subject_name: Bortezomib

object_name: renal cell adenocarcinoma


subject: CHEBI:52717

object_name: renal cell carcinoma


subject: CHEBI:52717

object_name: childhood kidney cell carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: EGFR Exon 19 Deletion Mutation


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C4078434

subject_name: lulizumab pegol

object_name: EXCESS LMW-DNA


subject: UMLS:C4078434

object_name: lupus vulgaris


subject: UMLS:C4078434

object_name: lupus erythematosus


subject: UMLS:C4078434

object_name: discoid lupus erythematosus


subject: UMLS:C4079852


subject: UMLS:C4079852


subject: UMLS:C4079852


subject: UMLS:C4079852


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Parkinson disease


subject: CHEBI:15927

object_name: neurodegenerative disease


subject: CHEBI:33330

subject_name: scandium atom

object_name: Overweight or obesity


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Myelodysplasia


subject: UNII:NQX9KB6PCL

object_name: Adult Myelodysplastic Syndrome


subject: UNII:NQX9KB6PCL

object_name: childhood myelodysplastic syndrome


subject: UNII:NQX9KB6PCL

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:NQX9KB6PCL

object_name: acute lymphoblastic leukemia


subject: UNII:NQX9KB6PCL

object_name: acute myeloid leukemia by FAB classification


subject: UNII:NQX9KB6PCL

object_name: acute myeloid leukemia


subject: UNII:NQX9KB6PCL

object_name: plasma cell myeloma


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: neuroendocrine neoplasm


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: neoplasm


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: cancer


subject: DRUGBANK:DB08937


subject: DRUGBANK:DB08937


subject: DRUGBANK:DB08937


subject: CHEBI:90876

subject_name: Lonsurf


subject: CHEBI:90876


subject: CHEBI:90876


subject: CHEBI:7465

subject_name: Naltrexone

object_name: pyromania


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: Ischemic stroke


subject: UNII:3S182ET3UA

subject_name: TINZAPARIN SODIUM


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UMLS:C1569697

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C1569697

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C1569697

object_name: anaplastic astrocytoma


subject: UMLS:C1569697

object_name: Adult Gliosarcoma


subject: UMLS:C1569697

object_name: gliosarcoma


subject: UMLS:C1569697

object_name: Childhood Gliosarcoma


subject: UMLS:C5206815

object_name: nasopharyngeal carcinoma


subject: UMLS:C5206815

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5206815

object_name: malignant tumor of nasopharynx


subject: DRUGBANK:DB08937

object_name: gastric adenocarcinoma


subject: DRUGBANK:DB08937

object_name: gastroesophageal cancer


subject: CHEBI:90876


subject: CHEBI:90876


subject: CHEBI:75722

subject_name: Tramadol

object_name: anxiety


subject: CHEBI:75722

object_name: anxiety disorder


subject: CHEBI:75722

object_name: Anxiety symptoms


subject: CHEBI:75722

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:75722

object_name: Anxiety, CTCAE 5.0


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: atherosclerosis


subject: CHEBI:567361

subject_name: Cladribine

object_name: sclerosing cholangitis


subject: CHEBI:184381

subject_name: Bacitracin

object_name: skin carcinoma


subject: UMLS:C3273249

subject_name: Topical Wound Spray HP802-247


subject: UNII:D07V79Q44T

object_name: prostate carcinoma


subject: UNII:D07V79Q44T

object_name: prostate cancer


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C5417815

subject_name: PARP7 Inhibitor RBN-2397

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: UMLS:C5706558

subject_name: Paclitaxel-conjugated CXCR4 Peptide Antagonist MB1707

object_name: ovarian cancer


subject: UMLS:C5706558

object_name: ovarian neoplasm


subject: UMLS:C5706558

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706558

object_name: breast carcinoma


subject: UMLS:C5706558

object_name: breast cancer


subject: UMLS:C5706558

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706558

object_name: non-small cell lung carcinoma


subject: UMLS:C5706558

object_name: pancreatic neoplasm


subject: CHEBI:28976

subject_name: carbonic acid

object_name: Acute kidney injury caused by contrast agent


subject: MESH:D001639

subject_name: Bicarbonates


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: arthritis